Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector.
Choroideremia is an outer retinal degeneration with a characteristic clinical appearance that was first described in the nineteenth century. The disorder begins with reduction of night vision and gradually progresses to blindness by middle age. The appearance of the fundus in sufferers is recognizab...
Main Authors: | Barnard, A, Groppe, M, Maclaren, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
Choroideremia: molecular mechanisms and development of AAV gene therapy
by: Patrício, M, et al.
Published: (2018) -
Enhancement of adeno-associated viral (AAV) gene therapy using hydroxychloroquine in murine and human tissues
by: Chandler, L, et al.
Published: (2019) -
Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes
by: McClements, M, et al.
Published: (2017) -
The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
by: Patrício, M, et al.
Published: (2018) -
Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
by: Tan, T, et al.
Published: (2017)